Looks like we will see notice of the TGA changing CBD from prescription only under SAS to OTC.
I am certain that Cannvalate and IHL are eyeing this closely, could make our oils sales explode!
I also recall that our clinical trial related drugs can be sold under SAS immediately, is it possible that if these changes go through that IHL will be able to sell its novel IP related drugs OTC across pharmacies and drug stores country wide?
Wednesday will be very interesting.